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Abstract
OBJECTIVE: To observe and compare the effects of
Chinese herbal prescriptions for promoting blood
circulation, clearing heat, removing toxicity, and
dispersing stagnated liver-Qi on cytokines in model
rats with experimental autoimmune prostatitis
(EAP) to provide an experimental basis for the use
of Chinese herbal prescriptions in the treatment of
chronic prostatitis.
METHODS: One-hundred and ten male Wistar rats
were randomly divided into 11 groups: blank
group; model group; Huoxuehuayu (promoting
blood circulation to remove blood stasis) high, mid-
dle, and low dose groups; Qingrejiedu (clearing
heat and removing toxicity) high, middle, and low
dose groups; and Shuganliqi (dispersing stagnated
liver-Qi) high, middle, and low dose groups. Except
the blank group, rats in all groups were injected
subcutaneously in multiple points on days 0 and 30
with prostatic protein extractive solution (60 mg/
mL), and intraperitoneally injected with diphthe-
ria-pertussis and tetanus vaccine (DPT vaccine) to
establish the EAP model. Model rats were adminis-
trated high, middle, and low doses of Chinese herb-
al prescriptions and were sacrificed after 4 weeks.
Pathological changes in the prostate gland were
observed with HE staining and changes in serum in-
terleukin-6 (IL-6), interleukin-8 (IL-8), and prosta-
glandin E2 (PGE2) levels were detected with en-
zyme-linked immunosorbent assay.
RESULTS: Compared with the blank group, serum
PGE2, IL-6, and IL-8 levels in the model group were
significantly higher (P < 0.05). Compared with the
model group, serum PGE2, IL-6, and IL-8 levels in the
Qingrejiedu low dose and middle dose groups
were significantly lower (P < 0.05), with the lower
dose having a more obvious effect. Serum PGE2,
IL-6, and IL-8 levels in the Huoxuehuayu high dose
group (P < 0.05), IL-6 and IL-8 levels in the Huoxue-
huayu middle dose group (P < 0.05), and the IL-8
level in the Huoxuehuayu low dose group were sig-
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nificantly lower than those in the model group
(P < 0.05). There were significant differences in
PGE2 and IL-6 levels among the different dose
groups of Shuganliqi drugs (P < 0.05). Compared
with the model group, serum PGE2, IL-6, and IL-8
levels in the Shuganliqi high dose group (P <
0.05) and IL-8 level in the Shuganliqi low dose
group were significantly lower (P < 0.05), while
the Shuganliqi middle dose group did not
change significantly (P > 0.05).
CONCLUSION: Therefore, in TCM treatment of auto-
immune prostatitis, different treatment methods
should select different doses. For prescriptions that
clear heat and remove toxicity, low doses should
be used. For prescriptions that promote blood cir-
culation to remove blood stasis and for prescrip-
tions that disperse stagnated liver-Qi, high doses
should be used.
© 2015 JTCM. All rights reserved.
Key words: Autoimmune disease; Prostatitis; Mod-
els, animal; Dinoprostone; Interleukins
INTRODUCTION
Chronic prostatitis is one of the most common pros-
tate diseases seen in clinic. Traditional Chinese Medi-
cine (TCM) has therapeutic effects on the disease, but
as there is little experimental research and the therapeu-
tic mechanisms are unclear, TCM popularization and
application is hindered. In recent years, immune re-
sponse in the role of pathogenic mechanisms of prosta-
titis has been increasingly studied, particularly with ex-
perimental autoimmune prostatitis (EAP). Research in-
dicates that the prostate gland has a local immune func-
tion for protecting the genital system against bacteria
and other pathogenic microorganisms.1 Abnormalities
in the local immune function of the prostate tissue can
induce corresponding changes in its physiological func-
tion, and even a series of pathological changes when it
is severe, indicating immune factors play an important
role in its genesis, development and transformation. In
the present study, an experimental autoimmune prosta-
titis rat model was established and treated with differ-
ent Chinese herbal prescriptions. Changes in serum
prostaglandin E2 (PGE2), interleukin-6 (IL-6), and in-
terleukin-8 (IL-8) before and after treatment were de-
tected to observe the therapeutic effects of different
Chinese herbal prescriptions and different doses on au-
toimmune prostatitis. These results give evidence for
the drug mechanism of action and provide a theoreti-
cal basis for the selection of different TCM therapeutic
methods and doses.
MATERIALS ANDMETHODS
Experimental animals
Two-hundred male Wistar rats, Specific pathogen free
grade, were supplied by the Experimental Animal Cen-
ter (SCKX [Xin] 2011-0001), and raised in the Depart-
ment of Experimental Animal Science Research, the
Medical Research Center, The First Affiliated Hospital
of Xinjiang Medical University. The body weight in 90
rats ranged from 300-350 g, and in 110 rats ranged
from 180-200 g. After the 110 male Wistar rats, aged
3 months, were adaptively raised for 1 week, they were
divided into 11 groups according to a random number
table. The groups were: blank group; model group;
Huoxuehuayu high-, middle-, and low-dose groups;
Qingrejiedu high-, middle-, and low-dose groups; and
Shuganliqi high-, middle-, and low-dose groups, with
10 rats in each group, except the blank group, which
had nine rats (one rat died in raising). Intraperitoneal
injection of the mixture (0.4 mL/100 g) of ketamine,
diazepam, and atropine was used for anesthesia before
the rat was sacrificed. Administration and experimental
studies all met the Requirements for Administration of
Experimental Animals (No. IACUC-20111125007)
stipulated by the Ethics Committee of Administration
and Use of Experimental Animals, the First Affiliated
Hospital, Xinjiang Medical University.
Drugs and reagents
The prescription for promoting blood circulation to re-
move blood stasis (Huoxuehuayu) was composed of:
Fuling (Poria) 10 g, Taoren (Semen Persicae) 10 g, Mu-
danpi (Cortex Moutan Radicis) 10 g, Chishao (Radix
Paeoniae Rubra) 10 g, Guizhi (Ramulus Cinnamomi) 9 g,
Zhiqiao (Fructus Aurantii Submaturus) 5 g, Danggui
(Radix Angelicae Sinensis) 9 g, Chuanxiong (Rhizoma
Chuanxiong) 9 g, Yanhusuo (Rhizoma Corydalis Yanhu-
suo) 9 g, Xiangfu (Rhizoma Cyperi) 9 g, and Honghua
(Flos Carthami) 9 g.
The prescription for dispersing stagnated liver-Qi
(Shuganliqi) was composed of: Wuyao (Radix Linderae
Aggregatae) 6 g, Muxiang (Radix Aucklandiae) 9 g, Juhe
(Semen Citri Reticulatae) 10 g, Qingpi (Fructus Citri Re-
ticulatae Immaturus) 10 g, Xiaohuixiang (Fructus Foe-
niculi) 3 g, Zhiqiao (Fructus Aurantii Submaturus) 10 g,
Chuanlianzi (Fructus Toosendan) 10 g, Yujin (Radix
Curcumae Wenyujin) 10 g, Baishao (Radix Paeoniae Al-
ba) 12 g, and Chaihu (Radix Bupleuri Chinensis) 9 g.
The prescription for clearing heat and removing toxici-
ty (Qingrejiedu) was composed of: Jinyinhua (Flos
Lonicerae) 15 g, Yejuhua (Flos Dendranthematis Indici)
10 g, Pugongying (Herba Taraxaci Mongolici) 10 g, Zi-
huadiding (Herba Violae Philippicae) 10 g, Dongkuig-
uo (Fructus Malvae Verticillatae) 10 g, Yiyiren (Semen
Coicis) 10 g, and Jiangcan (Bombyx Batryticatus) 6 g.
All herbs were purchased from Tongrentang Haozhou
Co. (Haozhou, China). Complete Freund's adjuvant
(FCA) (batch No. 101M8714) was from Sigma Co.,
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(St. Louis, MO, USA). Diphtheria-pertussis and teta-
nus vaccine (DPT vaccine) (batch No. 20110620-4)
was from Wuhan Institute of Biological Products (Wu-
han, China). Rat PGE2 (batch No. DRE20017), IL-8
(batch No. DRE20033), and IL-6 (batch No.
DRE20064) kits for enzyme-linked immunosorbent as-
say (ELISA) were purchased from Shanghai Xiangsh-
eng Biological Products Co., (Shanghai, China). Tri-
tonX-100 (batch No. T7200) was purchased from Bei-
jing Solar bio-Science and Technology Co., Ltd. (Bei-
jing, China).
Instruments
The 3-18 k high speed refrigerated centrifuge (Sigma,
Germany), the RV10 rotary evaporator. (IKA Co., Ger-
many), and the enzyme-linked immunoassay detector
was from BIO-RAD Co., (Hercules, CA, USA).
Establishment of the EAP rat model
Except for the rats in the blank group, rats in other
groups were modeled respectively on days 0 and 30
(60 mg/mL), and intraperitoneally injected with diph-
theria-pertussis and tetanus vaccine (DPT vaccine)3,4
Administration method
The administration dose of the rat was calculated ac-
cording to the equivalent body surface area method in
The Experimental Methodology of Pharmacology.5,6
The amount of crude drugs and administration doses
needed for the Huoxuehuayu, Qingrejiedu, and
Shuganliqi high-, middle-, and low-dose groups were
calculated with equal concentration methods. The
drug solutions were diluted to appropriate concentra-
tions with a rotary vaporizer on a water bath, respec-
tively corresponding to three-, two-, and one-fold the
equivalent dose, calculated according to the body sur-
face area between the human and the animal. The ad-
ministration was given by intragastric perfusion (equal
concentration method) from the second day (on day
31) after the second injection of modeling, once each
day, for 28 days.
Preparation of rat prostate protein extractive
solution
Ninety male Wistar rats, weighing 300-350 g, were in-
traperitoneally anesthetized under aseptic conditions
and a median incision on the lower abdomen was
made. The prostate tissue was removed without the ad-
hesive tissue, weighed, and then equal volume of saline
containing 0.5% Triton X-100 (Sigma, Germany) (pre-
liminary high temperature sterilization) was added.
The tissue was homogenized with a glass homogenizer
in an ice-water bath, and centrifuged at 10 000 r/min
(3000 ×g) for 30 min at 4 ℃. The supernatant was re-
moved for detection of protein with the biuret method,2
and the protein concentration of the extracted solution
was diluted to 60 mg/mL with PBS buffer.
Hematoxylin-eosin (HE) staining for observation of
pathological changes in the prostate
Rats were anesthetized intraperitoneally on the second
day after the final administration, and the abdominal
cavity was explored and blood was taken from the ab-
dominal aorta. Then, the prostate was removed and
rinsed with 0.9% saline, immersed in 10% neutral
formaldehyde for fixation, and embedded in paraffin.
After 4-µm sections were made and stained with hema-
toxylin-eosin, changes in histopathologic changes of
the mesenchyme and parenchyma were observed under
a light microscope.
Detection of serum cytokines with ELISA
Serum IL-6, IL-8, and PGE2 contents in the rats were
detected according to manufacturer's directions.
Statistical analysis
SPSS 17.0 statistical software (SPSS Inc., Chicago, IL,
USA) was used. For measurement data, one-way analy-
sis of variance was used for comparison between the
groups, and P < 0.05 was regarded as a statistically sig-
nificant difference. For paired comparison between
groups, least significant difference was used when vari-
ance was homogenous, and the Games-Howell method
was used when the variance was heterogeneous.
RESULTS
Pathological changes among the groups
In the blank group, the prostate tissues of the rats were
intact, and fibers between acinuses and the smooth
muscle were normally distributed, with no infiltration
of inflammatory cells in the lumen of the gland and
mesenchyme. There was also no hyperemia or edema.
In the model group, the lumen of the gland in the rats'
prostate tissues were dilated and enlarged, with secre-
tion visible in the lumen, and dilated blood vessels
with hyperemia. The epithelial cells of the acinus had
obvious papillary hyperplasia, the mesenchyme had ob-
vious fibrosis, and there were a great number of lym-
phocytes and plasma cells. Compared with the model
group, after administration of the drugs for promoting
blood circulation to remove blood stasis, clearing heat
and removing toxicity, and dispersing stagnated liv-
er-Qi, the proliferation of epithelial cells was improved,
the secretion of the cells was reduced, the inflamma-
tion disappeared to varying degrees, and the lumen of
the gland was enlarged. Epithelial cells mildly prolifer-
ated with a regular arrangement, and there was less se-
cretion in the lumen. These changes were particularly
obvious in the Qingrejiedu low-dose group, the Huox-
uehuayu high-dose group, and the Shuganliqi
high-dose group, and there were more reddish-staining
secretions in the lumen, similar to those in the blank
group (Figure 1).
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Effects of prescriptions on serum PGE2 levels in the
EAP rats
The serum PGE2 level in the model group was signifi-
cantly higher (P < 0.05) compared with the blank
group. After treatment with different drugs, serum
PGE2 levels decreased with significant statistical differ-
ences among the different doses of the three drugs (P <
0.05). Serum PGE2 levels in the Qingrejiedu low- and
middle-dose groups, the Huoxuehuayu high-dose
group, and the Shuganliqi high-dose group were lower
than those in the model group (P < 0.05). Serum
PGE2 levels in the Qingrejiedu groups increased along
with increased dosage, while serum PGE2 levels in the
Huoxuehuayu groups and the Shuganliqi groups de-
creased along with decreased dosage. There were signifi-
cant differences in decreases in serum PGE2 levels
among the three low-dose groups (P < 0.05), with the
best effect in the Qingrejiedu group. There was no sig-
nificant difference in decrease of PGE2 levels among
the three middle-dose groups (P > 0.05). There was a
significant difference among the three high-dose
groups in decrease of serum PGE2 levels, with the best
effect in the Huoxuehuayu group (Table 1).
Effects of prescriptions on serum IL-6 level in EAP
rats
Compared with the blank group, the IL-6 level was sig-
nificantly higher (P < 0.05) in the model group. After
treatment with different drugs, the serum IL-6 levels
all significantly decreased among the different doses of
the three drugs (P < 0.05). Serum IL-6 levels in the
Qingrejiedu low and middle-dose groups; the Huoxue-
huayu middle and high dose groups; and the Shugan-
liqi high-dose group were lower than those in the mod-
el group (all P < 0.05). The IL-6 levels in the Qingrejie-
du groups increased along with increases in dosage.
IL-6 levels in the Huoxuehuayu groups gradually de-
creased along with increased dosage. There were signifi-
cant differences among the three low dose groups (P <
0.05), with the best effect in the Qingrejiedu group,
and with no differences among the three middle- and
high-dose groups (P > 0.05) (Table 2).
Effects of prescriptions on serum IL-8 level in EAP
rats
Compared with the blank group, serum IL-8 was sig-
nificantly higher in the model group (P < 0.05). After
Figure 1 Pathological changes in the groups (HE staining, ×100)
A: blank group; B model group; C: Qingrejiedu low dose group; D: Qingrejiedu middle dose; E: Qingrejiedu high dose; F: Huoxue-
huayu low dose; G: Huoxuehuayu middle dose; H: Huoxuehuayu high dose; I: Shuganliqi low-dose group; J: Shuganliqi mid-
dle-dose group; K: Shuganliqi middle-dose group. HE: hematoxylin-eosin.
HG
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Table 1 Changes in serum prostaglandin E2 levels in EAP rats after treatment with different doses of drugs (ng/L)
Group
Qingrejiedu
Huoxuehuayu
Shuganliqi
Low dose (n=10)
382±48a
440±46
428±55
Middle dose (n=10)
405±42a
433±54
428±56
High dose (n=10)
434±52b
362±55ab
403±32a
Blank (n=9)
340±30a
340±30a
340±30a
Model (n=10)
468±54
468±54
468±54
Notes: Qingrejiedu (clearing heat and removing toxicity, 4 weeks); Huoxuehuayu (promoting blood circulation to remove blood stasis,
4weeks); Shuganliqi (dispersing stagnated liver-Qi, 4 weeks). EAP: experimental autoimmune prostatitis. Compared with the model group,
aP < 0.05; Compared with the low dose group, bP < 0.05.
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treatment with different drugs, serum IL-8 levels were
significantly lower in the Qingrejiedu low- and mid-
dle-dose groups, the Huoxuehuayu high-, middle-, and
low-dose groups, and the Shuganliqi low- and
high-dose groups as compared with the model group
(P < 0.05). There were no significant differences
among the three different doses of the three prescrip-
tions in effect on serum IL-8 (P > 0.05)( Table 3).
DISCUSSION
Chronic prostatitis is a common disease of the pros-
tate, possibly caused by infection, urine reflux, abnor-
mal immunity, stress, and other factors.7 Developments
in molecular biology and immunology have changed
research focus from the definition of cellular compo-
nents to regulation of mediators of inflammatory re-
sponse, with emphasis on the immune regulatory
mechanisms of inflammatory response.8 The cytokines
related with the inflammatory response include inter-
feron, the interleukin family, and tumor necrosis fac-
tor. The inflammatory factors involved in the present
study were PGE2, IL-6, and IL-8. Injury of local tissue
or inflammation can produce and release algogenic
chemical substances and PGE2. PGE2 promotes leuko-
taxis, strengthens capillary permeability, accelerates re-
lease of lysosomes and pyrogenic action, and is in-
volved in the entire inflammatory response.9 IL-6 is a
cytokine that produced as an autocrine or paracrine.
IL-6 can strength the production of IL-2 and T cells,10
and can induce neutrophilic granulocyte inflow into
the prostate tissue and activate T, B, and NK cells, pro-
mote degranulation of neutrophilic granulocytes, and
release lysosomes. These effects aggravate infiltration of
inflammatory cells, and promote inflammation.11 IL-8,
a pro-inflammatory factor, is produced by mononucle-
ar leukocytes, lymphocytes, granulocytes, and endothe-
lial cells, and is produced by endothelial cells, macro-
phages, and other cells after inflammatory stimula-
tion.12 IL-8 promotes chemotaxis causing the neutro-
philic granulocytes and mononuclear leukocytes to
leave the blood and cause inflammation.
In the present study, in the prescription for clearing
heat and removing toxicity, Jinyinhua (Flos Lonicerae),
Zihuadiding (Herba Violae Philippicae), Yejuhua (Flos
Dendranthematis Indici) mainly clear heat and remove
toxicity, cool blood, and reduce swelling. Meanwhile,
adjuvant drugs Dongkuiguo (Fructus Malvae Verticilla-
tae) and Yiyiren (Semen Coicis) clear heat, eliminate
damp, and activate blood circulation to reduce swell-
ing. The whole prescription clears damp heat to re-
move external pathogens and improve stagnation,
which restores the normal physiologic state of the pros-
tate. In the present study, it was found that after treat-
ment with the prescription for clearing heat and remov-
ing toxicity, serum PGE2, IL-6, and IL-8 levels were sig-
nificantly lower than those in the model group. This re-
sult indicates that the prescription has regulatory ac-
tion on algogenic and inflammatory factors. Previous
research on Jinyinhua (Flos Lonicerae Japonicae), in the
treatment of a fever rat model, has found that different
doses of Jinyinhua can eliminate inflammation.13 Zi-
huadiding (Herba Violae Philippicae) can clear heat and
remove toxicity, cool blood, and reducing swelling.14 Zi-
huadiding (Herba Violae Philippicae) can also strength-
en the immunity of organisms and cells.15 In TCM the-
ory, drugs that are bitter-cold in taste and nature can
spoil appetite, which influences therapeutic effect.
Therefore, in this experiment, the high prescription
dosage for clearing heat and removing toxicity could
not significantly decrease PGE2, IL-6, and IL-8 levels
in the model mouse, while the low dose could.
In the prescription for promoting blood circulation to
remove blood stasis, Taoren (Semen Persicae), Honghua
(Flos Carthami), and Chishao (Radix Paeoniae Rubra)
mainly promote blood circulation to remove blood sta-
Group
Qingrejiedu
Huoxuehuayu
Shuganliqi
Low dose (n=10)
100±11a
123±19
122±21
Middle dose (n=10)
108±13a
115±7a
121±13
High dose (n=10)
116±14b
109±10ab
121±12a
Blank (n=9)
75±8a
75±8a
75±8a
Model (n=10)
128±18
128±18
128±18
Notes: Qingrejiedu (clearing heat and removing toxicity, 4 weeks); Huoxuehuayu (promoting blood circulation to remove blood stasis,
4weeks); Shuganliqi (dispersing stagnated liver-Qi, 4 weeks). EAP: experimental autoimmune prostatitis. Compared with the model group,
aP < 0.05; Compared with the low dose group, bP < 0.05.
Table 2 Changes in serum interleukin-6 levels in EAP rats after treatment with different prescriptions (ng/L)
Group
Qingrejiedu
Huoxuehuayu
Shuganliqi
Low dose (n=10)
638±170a
663±144a
669±122a
Middle dose (n=10)
669±125a
655±72a
675±150
High dose (n=10)
669±137
649±128a
660±40a
Blank (n=9)
654±254a
654±254a
654±254a
Model (n=10)
811±61
811±61
811±61
Table 3 Changes in serum interleukin-8 levels in EAP rats after treatment with different prescriptions (ng/L)
Notes: Qingrejiedu (clearing heat and removing toxicity, 4 weeks); Huoxuehuayu (promoting blood circulation to remove blood stasis,
4weeks); Shuganliqi (dispersing stagnated liver-Qi, 4 weeks). EAP: experimental autoimmune prostatitis. Compared with the model group,
aP < 0.05.
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sis, resolve masses, and disperse stagnation. Zhiqiao
(Fructus Aurantii Submaturus), Xiangfu (Rhizoma Cy-
peri), and Yanhusuo (Rhizoma Corydalis Yanhusuo) dis-
perse the stagnated liver-Qi and regulate Qi, remove
stagnancy, resolve mass, promote blood circulation,
and improve local micro-circulation. Mudanpi (Cortex
Moutan Radicis) and Chishao (Radix Paeoniae Rubra)
cool blood, clear heat, reduce swelling, remove stagnat-
ed heat, and relieve degree of fibrosis. Guizhi (Ramulus
Cinnamomi) warms Yang, removes blood stasis, and reg-
ulates Yin and Yang. The entire prescription promotes
blood circulation and removes blood stasis, disperses
the stagnated liver-Qi, removes blood stasis, and clears
heat. The results of the study indicate that after admin-
istration of the prescription for promoting blood circu-
lation and removing blood stasis, serum PGE2, IL-6,
and IL-8 levels in the rat were lower than those in the
model group. The levels were lower when the dosage
was increased. The mechanism for treatment of prosta-
titis is possibly that the drugs for promoting blood cir-
culation and removing blood stasis can improve micro-
circulation, increase local blood perfusion, and pro-
mote drug entrance into the gland lumen. These ef-
fects relieve chronic inflammatory obstructions of the
prostate, unblock the prostate lumen,16 regulate the se-
cretory function of the prostate, increase immunity,
stimulate proliferation of the reticuloendothelial sys-
tem, promote phagocytosis of white cells, and alleviate
dysfunction of the pelvic floor muscles.17
In the prescription for dispersing stagnated liver-Qi,
Wuyao (Radix Linderae Aggregatae) and Xiaohuixiang
(Fructus Foeniculi) disperse the stagnated liver-Qi, dis-
pel cold, and relieve pain. Juhe (Semen Citri Reticula-
tae), Qingpi (Fructus Citri Reticulatae Immaturus), and
Chuanlianzi (Fructus Toosendan) relieve stagnated liv-
er-Qi, disperse stagnation, relieve pain, and promote
blood circulation. Baishao (Radix Paeoniae Alba) nour-
ishes liver blood, relieves spasms and pain, and avoids
consumption of liver-Yin owing to the over pungent
and dispersing action of the drugs. The entire prescrip-
tion disperses the stagnated liver-Qi, and relieves stag-
nation and pain. In the study, it was found that after
treatment with the drugs for dispersing the stagnated
liver-Qi, serum PGE2, IL-6, and IL-8 levels were lower
as compared with the model group, with the higher
dose having a larger effect. The treatment is mainly
based on the TCM theory that "the Liver Meridian
goes along the Yin organs, and is in charge of dispers-
ing." Pain and distending pain in the perineum or the
low abdomen are the main manifestations of chronic
prostatitis. Pharmacologic study indicates that Chaihu
(Radix Bupleuri Chinensis) in the prescription can: re-
lieve spasms; act as a tranquilizer; act as an anti-inflam-
matory, analgesic, anti-viral, and anti-histamine; in-
duce the production of interferon; and promote im-
mune function.18,19 Yujin (Radix Curcumae Wenyujin)
promotes blood circulation and removes blood stasis,
clears heart-fire to relieve depression, promotes Qi cir-
culation to relieve pain, and has immunosuppressive ac-
tion in regulating immune function.20 In addition, Yu-
jin (Radix Curcumae Wenyujin) can promote diuresis,
relieve stranguria, and help to improve the stimulating
symptoms of prostate in urination.
The above results indicate that the drugs for clearing
heat and removing toxicity (low dose), the drugs for
promoting blood circulation and removing blood stasis
(high dose), and the drugs for dispersing stagnated liv-
er-Qi (high dose) can alleviate infiltration of inflamma-
tory cells and proliferation of fibrous tissue in prostati-
tis rats. These drugs can also restore the secretory func-
tion of the prostate epithelial cells, and strengthen the
anti-inflammatory action and the ability of the pros-
tate to restore injured tissue. These effects have a pro-
tective effect on the prostate, which provides support-
ing evidence for the use of Chinese drugs in treating
autoimmune prostatitis.
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